Elicio Therapeutics, Inc.
ELTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001601485
No open-market purchases or sales by Elicio Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $15.3M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Elicio Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- +7 vs. Q2 2025
- Shares held
- 1.91M
- +460.5K (+31.7%) vs. Q2 2025
- Total value
- $20.9M
- +$9.69M (+86.6%) vs. Q2 2025
- New holders
- 10
- 9 more added
- Sold out
- 3
- 2 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 48 | $15.3M |
| Q1 2026 | 47 | $28.2M |
| Q4 2025 | 37 | $16.6M |
| Q3 2025 | 28 | $20.9M |
| Q2 2025 | 21 | $11.2M |
| Q1 2025 | 24 | $9.80M |
| Q4 2024 | 17 | $2.25M |
| Q3 2024 | 18 | $2.48M |
| Q2 2024 | 20 | $2.68M |
| Q1 2024 | 18 | $3.08M |
| Q4 2023 | 18 | $2.78M |
| Q3 2023 | 18 | $2.80M |
| Q2 2023 | 15 | $2.71M |
| Q1 2023 | 28 | $2.56M |
| Q4 2022 | 30 | $3.98M |
| Q3 2022 | 38 | $4.71M |
| Q2 2022 | 43 | $5.90M |
| Q1 2022 | 47 | $13.8M |
| Q4 2021 | 53 | $20.3M |
| Q3 2021 | 47 | $69.3M |
| Q2 2021 | 41 | $66.5M |
| Q1 2021 | 41 | $92.0M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Elicio Therapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SBI Securities Co., Ltd. | 82 | $897 | 0.00% | −1−1.2% | Reduced |
| Simplex Trading, LLC | 103 | $1.00K | 0.00% | +103 | New |
| Wells Fargo & Company | 200 | $2.19K | 0.00% | +200 | New |
| Farther Finance Advisors, LLC | 640 | $7.00K | 0.00% | +640 | New |
| Morgan Stanley | 1,536 | $16.8K | 0.00% | +1,156+304.2% | Added |
| Steward Partners Investment Advisory, LLC | 1,554 | $17.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 3,585 | $39.2K | 0.00% | +2,335+186.8% | Added |
| CIBC Private Wealth Group, LLC | 7,000 | $42.6K | 0.00% | 00.0% | Unchanged |
| Jefferies Financial Group Inc. | 5,200 | $56.9K | 0.00% | +5,200 | New |
| CM Management, LLC | 6,000 | $65.6K | 0.05% | −19,000−76.0% | Reduced |
| UBS Group AG | 7,019 | $76.8K | 0.00% | +996+16.5% | Added |
| Wiley Bros.-Aintree Capital, LLC | 10,000 | $109.4K | 0.00% | 00.0% | Unchanged |
| Moody Lynn & Lieberson, LLC | 10,000 | $109.4K | 0.01% | 00.0% | Unchanged |
| Mayflower Financial Advisors, LLC | 10,000 | $109.4K | 0.01% | 00.0% | Unchanged |
| Citigroup Inc | 10,658 | $116.6K | 0.00% | +10,658 | New |
| Meyer Handelman Co | 13,899 | $152.1K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 22,846 | $249.9K | 0.00% | +22,846 | New |
| Cresset Asset Management, LLC | 26,925 | $294.6K | 0.00% | +26,925 | New |
| State Street Corp | 38,300 | $419.0K | 0.00% | +16,700+77.3% | Added |
| BlackRock, Inc. | 44,195 | $483.5K | 0.00% | +638+1.5% | Added |
| Renaissance Technologies LLC | 48,671 | $532.5K | 0.00% | +48,671 | New |
| Northern Trust Corp | 53,584 | $586.2K | 0.00% | +2,584+5.1% | Added |
| Marshall Wace, LLP | 86,533 | $946.7K | 0.00% | +86,533 | New |
| Susquehanna International Group, LLP | 120,207 | $1.32M | 0.00% | +103,184+606.1% | Added |
| Geode Capital Management, LLC | 129,686 | $1.42M | 0.00% | +8,855+7.3% | Added |
| Balyasny Asset Management LLC | 148,076 | $1.62M | 0.00% | +148,076 | New |
| Vanguard Group Inc | 473,859 | $5.18M | 0.00% | +19,240+4.2% | Added |
| Knoll Capital Management, LLC | 630,915 | $6.90M | 3.70% | 00.0% | Unchanged |
| Quantinno Capital Management LP | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −6,000−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −82−100.0% | Sold out |